BioSpace News Archive

FDA

Centinel Spine Announces 510(k) Clearance of FLX™ Platform of 3D Printed All-Titanium Interbodies

Centinel Spine, LLC is pleased to announce that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its FLX™ Platform of Integrated Interbody™ and non-integrated interbody fusion devices.

June 7, 2018
·
3 min read
Pharm Country

InventHelp Inventor Develops Full Coverage Disposable Glove (CBA-3315)

Medical gloves provide a barrier between the medical professional and the patient, protecting the doctor or nurse from bodily fluids and protecting the patient from cross-contamination or infection.

June 7, 2018
·
1 min read
BioForest

Red Cross Trains 1 Million Children to Prepare for Disasters through The Pillowcase Project

Empowered students are using what they learned in the American Red Cross program to save lives

June 7, 2018
·
2 min read
Genetown

Early 2019 insurance rates highlight a need for benefit alternatives

Insurance Consultant ClaimLinx offers employers a solution for rising health care costs

June 7, 2018
·
2 min read
Business

Food Allergy Research & Education Names Lisa Gable Chief Executive Officer

Executive with Business, Government and Nonprofit Leadership Experience Selected to Lead National Food Allergy Organization

June 7, 2018
·
2 min read
FDA

Ironwood Pharmaceuticals Announces FDA Orphan Drug Designation for Olinciguat for the Treatment of Sickle Cell Disease

Ironwood Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to olinciguat (IW-1701) for the treatment of patients with sickle cell disease.

June 7, 2018
·
7 min read
Biotech Beach

AmpliPhi Biosciences Announces Presentation of Bacteriophage Therapy Case Studies at American Society of Microbiology Annual Meeting

AmpliPhi Biosciences Corporation announced a late-breaker poster presentation describing four case studies of patients suffering from severe Staphylococcus aureus (S. aureus) infections, who received treatment with AB-SA01, AmpliPhi’s investigational bacteriophage drug candidate.

June 7, 2018
·
4 min read